跳至主要内容
临床试验/ACTRN12613000888763
ACTRN12613000888763已完成4 期

Does treatment with Serenoa Repens results in improvement of inflammation score compared to no treatment, in men with histologically prostatic inflammation?

Prof. Stavros Gravas0 个研究点目标入组 100 人开始时间: 2013年8月8日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 85 Years(—)
性别
Male

入选标准

  • Patients with proven inflammation in prostatic biopsy

排除标准

  • Patients who have been already treated for LUTS with herbal medication.
  • Patients who have been diagnosed with prostate cancer at the first biopsy.
  • Patients who underwent pelvic radiotherapy for any reason.
  • Patients with a permanent urethral catheter.
  • Patient with a previous TURP or intravesical instillations due to bladder cancer.

研究者

发起方
Prof. Stavros Gravas

相似试验

Study of the effect of Serenoa Repens on prostatic... | 临床试验